Ozurdex in PVR Following Retinal Detachment

Show Description +

This patient presented with a primary retinal detachment with two tears. We planned a vitrectomy, endolaser, and gas tamponade.

Posted: 10/26/2020

Keywords:

OZURDEX

•

Proliferative Vitreoretinopathy (PVR)

•

Retinal detachment, RD

Up Next

Name: Ozurdex in PVR Following Retinal Detachment
Uploaded: 2020-10-26T09:28:00+00:00
Description: This patient presented with a primary retinal detachment with two tears. We planned a vitrectomy, endolaser, and gas tamponade.

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

Stanislao Rizzo, MD

Pinhole Effect in Double Peel for Macular Hole

Hudson de Carvalho Nakamura, MD

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Frederic Aissani, MD

Macular Hole Surgery: Retinal Massager

Manish Nagpal, MS, DO, FRCS(UK)

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Frederic Aissani, MD

The Big Mac: ILM Technique for Large Macular Holes

Hudson Nakamura, MD

ILM Peel for Macular Hole Under Liquid PFC

Hudson Nakamura, MD

My Peeling Technique for a Dense Plaque on the Posterior Capsule

Ashraf Armia, FRCSG, FACS

Experience a New Dimension: How Eyetube3D Works!

25-Gauge Vitrectomy for Retained Lens Fragments

Yoreh Barak, MD, Lana Rifkin, MD, Omar Saleh, MD, Shlomit Schaal, MD, PhD

Ozurdex in PVR Following Retinal Detachment

Frederic Aissani, MD

This patient presented with a primary retinal detachment with two tears. We planned a vitrectomy, endolaser, and gas tamponade.

Posted: 10/26/2020

Keywords:

OZURDEX

•

Proliferative Vitreoretinopathy (PVR)

•

Retinal detachment, RD

Please log in to leave a comment.

More in Retina

Can Metformin Use Cut Wet AMD Risk?

Maria Berrocal, MD and Dimitra Skondra, MD, PhD

Vitreous Hemorrhage Following PVD: Who Needs Surgery?

Barton Blackorby, MD, Matt Starr, MD, and Kyle Kovacs, MD

YAG Laser Embolysis

Saksonov Stanislav; Teslenko Olexandr; and Dmytrulina Nikolietta

Does Preoperative Anti-VEGF Change Outcomes in Non-Tractional Vitreous Hemorrhage?

Maria Berrocal, MD and Sumit Sharma, MD